142 related articles for article (PubMed ID: 17632968)
1. New dietary ingredient notifications: a comprehensive review and strategies for avoiding FDA objections.
Talati AR
Food Drug Law J; 2007; 62(2):387-98. PubMed ID: 17632968
[No Abstract] [Full Text] [Related]
2. Regulating dietary supplement safety under the dietary supplement health and education act: brave new world or pyrrhic victory?
Silverglade BA
Food Drug Law J; 1996; 51(2):319-21. PubMed ID: 11822324
[No Abstract] [Full Text] [Related]
3. Can claims, misleading information, and manufacturing issues regarding dietary supplements be improved in the United States?
Gibson JE; Taylor DA
J Pharmacol Exp Ther; 2005 Sep; 314(3):939-44. PubMed ID: 15833895
[TBL] [Abstract][Full Text] [Related]
4. Structure/function claims in dietary supplement labeling: not all of these claims need to be submitted to FDA and accompanied in labeling by the DSHEA disclaimer.
McNamara SH
Food Drug Law J; 1999; 54(1):35-42. PubMed ID: 11758558
[No Abstract] [Full Text] [Related]
5. Dietary supplements: what is in the public's best interest?
Talbott SM
Science; 1999 Dec; 286(5448):2269-70; author reply 2270-1. PubMed ID: 10636786
[No Abstract] [Full Text] [Related]
6. The Dietary Supplement Health and Education Act.
Young AL; Bass IS
Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995
[No Abstract] [Full Text] [Related]
7. Premarket notifications of new dietary ingredients--a ten-year review.
McGuffin M; Young AL
Food Drug Law J; 2004; 59(2):229-44. PubMed ID: 15318394
[No Abstract] [Full Text] [Related]
8. Regulation of dietary supplements: five years of DSHEA.
Khatcheressian LA
Food Drug Law J; 1999; 54(4):623-44. PubMed ID: 11824458
[No Abstract] [Full Text] [Related]
9. Dietary supplements and lessons to be learned from GRAS.
Burdock GA
Regul Toxicol Pharmacol; 2000 Feb; 31(1):68-76. PubMed ID: 10715226
[TBL] [Abstract][Full Text] [Related]
10. FDA has substantial and sufficient authority to regulate dietary supplements.
McNamara SH; Siegner AW
Food Drug Law J; 2002; 57(1):15-24. PubMed ID: 12118477
[No Abstract] [Full Text] [Related]
11. From aspartame to Xenical. A look at the FDA review process.
Trissler RJ
J Am Diet Assoc; 1999 Jul; 99(7):797-8. PubMed ID: 10405675
[No Abstract] [Full Text] [Related]
12. Dietary supplements: background for dialogue between the industry and the medical profession.
Friede AI
Food Drug Law J; 1998; 53(3):413-20. PubMed ID: 10346719
[No Abstract] [Full Text] [Related]
13. FDA regulation of ingredients in dietary supplements after passage of the Dietary Supplement Health and Education Act of 1994: an update.
McNamara SH
Food Drug Law J; 1996; 51(2):313-8. PubMed ID: 11822323
[No Abstract] [Full Text] [Related]
14. FDA notifications. Labeling rule proposed for dietary supplements.
AIDS Alert; 2003 Jul; 18(7):90-1. PubMed ID: 12846199
[No Abstract] [Full Text] [Related]
15. FDA hearing highlights opposition to dietary supplement practices; written comments due August 20. Food and Drug Administration.
James JS
AIDS Treat News; 1999 Aug; (No 324):3-4. PubMed ID: 11366575
[TBL] [Abstract][Full Text] [Related]
16. The FDA, medical foods, and patents.
Czap A
Altern Med Rev; 2002 Oct; 7(5):367-8. PubMed ID: 12410621
[No Abstract] [Full Text] [Related]
17. Dietary supplements of botanicals and other substances: a new era of regulation.
McNamara SH
Food Drug Law J; 1995; 50(3):341-8. PubMed ID: 10343003
[No Abstract] [Full Text] [Related]
18. Food industry initiatives to improve the FDA's food ingredient review processes.
Pape SM
Food Drug Law J; 1996; 51(3):413-21. PubMed ID: 11797718
[No Abstract] [Full Text] [Related]
19. Regulation of dietary supplements: FDA's strategic plan.
Levitt JA
Food Drug Law J; 2002; 57(1):1-13. PubMed ID: 12118474
[No Abstract] [Full Text] [Related]
20. A millstone in the uphill battle for credibility.
Czap A
Altern Med Rev; 2001 Feb; 6(1):3. PubMed ID: 11207452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
